middle.news
Paradigm gets one more chance to keep recapitalisation alive
8:48am on Friday 23rd of October, 2026 AEDT
•
Biotechnology
Read Story
Paradigm gets one more chance to keep recapitalisation alive
8:48am on Friday 23rd of October, 2026 AEDT
Key Points
Up to three-month extension sought for second creditors meeting
Court hearing scheduled for 27 October 2026
Board-led recapitalisation and sale proposals remain under assessment
Independent analysis of the PARA_012 Phase 3 trial is outstanding
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Paradigm Biopharmaceuticals (ASX:PAR)
OPEN ARTICLE